Top 25 Companies in Biotechnology Instruments Market in the World in 2025: Market Research Report (2024–2035)
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Biotechnology Instruments Market Size is projected to Grow from USD 81.4 Billion in 2024 to USD 181.4 Billion by 2035, at a CAGR of 8.34 % during the forecast period 2025–2035. The Biotechnology Instruments Market is poised for significant opportunities as advances in life sciences, healthcare, and pharmaceuticals accelerate. Growing demand for personalized medicine, genomics, and proteomics research will drive the adoption of advanced instruments for DNA sequencing, molecular diagnostics, and biomarker discovery.
Introduction
The Biotechnology Instruments Market plays a crucial role in advancing life sciences, pharmaceuticals, and healthcare by providing essential tools for research, diagnostics, and therapeutic development. These instruments include systems for DNA sequencing, electrophoresis, chromatography, spectroscopy, and imaging, enabling scientists to explore biological processes at the molecular level. With the growing emphasis on personalized medicine, drug discovery, and disease diagnostics, biotechnology instruments have become indispensable in modern laboratories and clinical settings. The market is witnessing strong growth, fueled by increasing R&D investments, technological advancements, and rising demand for innovative solutions to address global healthcare and biopharmaceutical challenges.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Biotechnology Instruments market.
Biotechnology Instruments Market Size & Statistics
- The Market for Biotechnology Instruments Was Estimated to be Worth USD 81.4 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 8.34 % Between 2025 and 2035.
- The Global Biotechnology Instruments Market Size is Anticipated to Reach USD 181.4 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Biotechnology Instruments market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Biotechnology Instruments market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Biotechnology Instruments market. This trend is mainly responsible for the rapid advancement of biotechnology industries in emerging economies like China, Japan, South Korea, Australia, and India. The robust governmental backing for biotechnology in these countries further propels industry expansion. Ongoing R&D investments further boost the demand for biotechnology instruments. Additionally, increasing research spending and government funding are anticipated to fuel market growth in the Asia Pacific area.
North America is expected to generate the highest demand during the forecast period in the Biotechnology Instruments market. This is because of the area's increased prevalence of target diseases, aging population, extensive use of point-of-care diagnostic tests/devices, and rising demand for intravenous drug instruments. Moreover, heightened R&D efforts and growing public-private research funding enhance demand, resulting in market growth. Moreover, continuous breakthroughs and increased government funding in biotechnology tools, along with the affordable implementation of new technologies, bolster the United States' status as the globe's most lucrative market. Additionally, many companies in this area are collaborating to tackle socioeconomic and environmental issues, thereby promoting the expansion of the North American biotechnology instruments market during the projected period.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Biotechnology Instruments market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 5 Emerging Technologies & Startups
1. Biosensors
Combining biological and electronic components, Biosensors measure and monitor many analytes such as organic compounds and bacteria with great precision. Since Biosensors are typically deployed inside a patient’s body, they are able to monitor analytes that cannot be measured by external devices. When equipped with advanced microelectronic components, Biosensors also function as a part of the Internet of Things (IoT) to deliver data to physicians in real-time.
2. 3D Bioprinting
3D Bioprinting uses so-called “bioink” material to create tissue-like structures layer-by-layer. With appropriate bioink material, pills and drugs can be printed on-demand with much lower costs involved. Bioprinted tissues also have a wide range of usage in research and regenerative medicine, such as printing living cells, creating functional tissues to repair or replace organs.
3. Tissue Engineering
Tissue Engineering combines bioengineering and biochemical methods to improve, replace, or create biological tissues (i.e. bone, blood vessels, skin, muscle etc.). A more promising but controversial method is to use stem cells to grow and replicate entire organs of patients, without these patients needing transplants.
4. Gene Editing
Gene editing technology has been greatly enhanced by the early 2000s’ discovery and further development of using CRISPR-Cas9 for precise insertion, modification, and deletion of DNA sequences in the genome. It has made genetic engineering widely available at a fraction of the cost of earlier methods. CRISPR-Cas9’s applications not only allow physicians to perform affordable gene therapy but can also be used to prevent genetic diseases and potentially enhance human genetics.
5. Synthetic Biology & Metabolic Engineering
Combines advanced disciplines of biology and engineering (such as genetic and metabolic engineering) to design and construct biological modules, systems or machines. For example, Synthetic Biology is used to create synthetic meat to reduce animal suffering and greenhouse gas production; synthetic biology can also increase the production of chemicals, fuels, and materials from renewable biomass.
Top 18 Companies Leading the Biotechnology Instruments Market
- Zeiss Group
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Mettler Toledo
- Endress+Hauser
- Bruker Corp.
- PerkinElmer, Inc.
- Eppendorf SE
- Danaher
- bioMérieux SA
- Bruker Corp.
- Sartorius AG
- Waters Corp.
- Avantor, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
1. Zeiss Group
Headquarters: Oberkochen, Germany
Zeiss Group is a global leader in optics and optoelectronics, providing advanced instruments for healthcare, research, and industrial applications. The company offers high-precision solutions in microscopy, medical technology, semiconductor manufacturing equipment, and quality assurance. In biotechnology, Zeiss is renowned for its innovative microscopy and imaging systems that support life science research, cell biology, and clinical diagnostics. With a strong emphasis on R&D and digitalization, Zeiss integrates artificial intelligence and automation into its instruments, enabling cutting-edge discoveries. Its commitment to sustainability, innovation, and global partnerships makes Zeiss a trusted name in advancing scientific research and healthcare solutions worldwide.
2. Abbott Laboratories
Headquarters: Abbott Park, Illinois, United States
Abbott Laboratories is a global healthcare company specializing in diagnostics, medical devices, nutrition, and branded generic medicines. In biotechnology instruments, Abbott is recognized for its advanced diagnostic systems, immunoassay analyzers, and molecular testing platforms. The company plays a critical role in improving healthcare outcomes by providing reliable tools for disease detection, monitoring, and personalized medicine. Abbott’s innovations in point-of-care diagnostics and laboratory automation have enhanced the efficiency of clinical workflows worldwide. With a strong focus on accessibility, innovation, and patient care, Abbott continues to expand its global footprint while addressing critical healthcare challenges through cutting-edge biotechnology solutions.
3. Thermo Fisher Scientific, Inc.
Headquarters: Waltham, Massachusetts, United States
Thermo Fisher Scientific, Inc. is a global leader in biotechnology instruments, life sciences, and laboratory solutions. Its extensive portfolio includes systems for DNA sequencing, mass spectrometry, chromatography, microscopy, and laboratory automation. Thermo Fisher empowers scientists, researchers, and healthcare providers to accelerate discoveries, improve diagnostics, and advance biopharmaceutical production. The company is instrumental in driving innovation in personalized medicine, clinical diagnostics, and drug development. With a global presence and strong emphasis on R&D, Thermo Fisher integrates AI, data analytics, and automation into its instruments. Its mission to enable a healthier, cleaner, and safer world makes it a trusted partner in science.
4. Illumina, Inc.
Headquarters: San Diego, California, United States
Illumina, Inc. is a pioneer in genomics and biotechnology instruments, specializing in DNA sequencing and array-based technologies. Its platforms enable researchers and clinicians to analyze genetic variation and function with unmatched accuracy and scale. Illumina’s sequencing instruments are widely used in genomics research, oncology, reproductive health, and precision medicine. By advancing next-generation sequencing (NGS) technologies, Illumina has transformed fields such as personalized medicine and disease diagnostics. The company also invests in AI-driven bioinformatics solutions to enhance genomic data interpretation. Illumina’s focus on innovation and global accessibility positions it as a leader in unlocking the power of the genome.
5. Mettler Toledo
Headquarters: Columbus, Ohio, United States
Mettler Toledo is a global leader in precision instruments and services for laboratory, industrial, and food retail applications. In biotechnology, the company is recognized for its analytical instruments, balances, pipettes, and process analytics systems that ensure accuracy and efficiency in research and production. Mettler Toledo’s advanced solutions support drug discovery, quality control, and laboratory automation. The company emphasizes innovation through digital integration, automation, and real-time monitoring technologies that streamline workflows and improve reproducibility. With a strong focus on precision and reliability, Mettler Toledo remains a trusted partner for biotechnology, pharmaceutical, and life sciences industries worldwide.
Are you ready to discover more about the Biotechnology Instruments market?
The report provides an in-depth analysis of the leading companies operating in the global Biotechnology Instruments market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Zeiss Group.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Mettler Toledo
- Endress+Hauser
- Bruker Corp.
- PerkinElmer, Inc.
- Eppendorf SE
- Danaher
Conclusion
The Biotechnology Instruments Market is experiencing robust growth as technological innovations, rising healthcare demands, and expanding applications in life sciences continue to reshape the industry landscape. From advanced DNA sequencing and molecular diagnostics to precision instruments that accelerate drug discovery, these tools are becoming indispensable in driving breakthroughs across healthcare, pharmaceuticals, and research. With North America leading adoption and Asia Pacific emerging as a fast-growing hub, global opportunities are vast. As investments in R&D, automation, and digitalization expand, biotechnology instruments will play a central role in enabling personalized medicine, advancing scientific discovery, and addressing global healthcare challenges.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?